<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00552435</url>
  </required_header>
  <id_info>
    <org_study_id>MP-001</org_study_id>
    <nct_id>NCT00552435</nct_id>
  </id_info>
  <brief_title>Micropulse 810 Nanomolar (nm), Diode Laser for Diffuse Diabetic Macular Edema</brief_title>
  <official_title>Phase 2 Study of Micropulse 810nm Diode Laser Photocoagulation for Treatment of Diffuse Diabetic Macular Edema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <brief_summary>
    <textblock>
      Objective: To compare micropulse 810nm diode laser photocoagulation versus argon laser
      photocoagulation for treatment of diabetic macular edema. Micropulse laser technique will be
      determined by an initial clinical trial comparing single versus double density laser
      photocoagulation techniques for treatment of diabetic macular edema.The single density is
      based on the Early Treatment Diabetic Retinopathy Study (ETDRS) grid photocoagulation
      technique and the double density increases the number of spots.

      Methods: Patients with diabetic macular edema will be assigned to receive either micropulse
      810nm diode laser photocoagulation or argon laser photocoagulation therapy. First, in a
      smaller clinical trial, patients will be assigned to single or double density micropulse
      810nm diode laser to determine best strategy for this therapy. Visual acuity, fundus
      photographs and fluorescein angiography, and optical coherence tomography measurements ,
      autofluorescence and mfERG were obtained at baseline and at 1, 3 and 6 months and 12 months.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2007</start_date>
  <completion_date type="Anticipated">November 2008</completion_date>
  <primary_completion_date type="Anticipated">November 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Macular thickness measured by optical coherence tomography (OCT)</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety profile</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selectivity of laser therapy (autofluorescence and mfERG)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Diabetic Macular Edema</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Micropulse 810nm diode laser</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Argon laser photocoagulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser photocoagulation</intervention_name>
    <description>Laser therapy is applied using a slit lamp and specific laser contact lens.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes mellitus (type 1 or 2)

          -  Diabetic macular edema in study eye associated to diabetic retinopathy

          -  Diffuse macular edema defined as macular thickening determined by biomicroscopy and
             fluorescein angiography.

          -  Best corrected visual acuity between 34 (20/200) and 68 letters (20/50).

          -  Macular thickness greater than 300 mcm on OCT.

        Exclusion Criteria:

          -  Uncontrolled systemic disease

          -  Start of medical therapy for diabetes or change in treatment from oral to insulin four
             months before initial visit.

          -  HbA1c levels greater than 10%

          -  Presence of retinal venous occlusion, cystoid macular edema,or other condition that
             would contribute to macular edema.

          -  Presence of epiretinal membrane

          -  Presence of vitreomacular traction in the study eye.

          -  Neovascularization of disc or elsewhere in the study eye.

          -  History or presence of choroidal neovascularization in the study eye.

          -  Presence of rubeosis irides in the study eye.

          -  Eye opacity that interfere with clinical documentation and photography.

          -  Intra-ocular surgery 90 days before initial visit.

          -  Scheduled surgery for study eye.

          -  Patients with known allergies to fluorescein.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose A Cardillo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sao Paulo- Department of Ophthalmology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Lavinsky</last_name>
    <phone>55-11-7658-8669</phone>
    <email>lavinsky@via-rs.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jose A Cardillo</last_name>
    <phone>55-16-8115-1000</phone>
    <email>hospitaldeolhos@uol.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vision Institute, Federal University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Lavinsky, MD</last_name>
      <phone>55-11-7658-8669</phone>
    </contact>
    <investigator>
      <last_name>Jose A Cardillo</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel E Farah</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paulo Hilarião</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leonardo Castro</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Lavinsky</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2007</study_first_submitted>
  <study_first_submitted_qc>October 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2007</study_first_posted>
  <last_update_submitted>May 6, 2008</last_update_submitted>
  <last_update_submitted_qc>May 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2008</last_update_posted>
  <responsible_party>
    <name_title>Federal University of Sao Paulo</name_title>
    <organization>Vision Institute Department of Ophthalmology</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
    <mesh_term>Macular Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

